Novartis (NVS) Financial Analysis & Valuation | Quarter Chart

Novartis (NVS)

NVS
Price: $148.26
Fair Value: 🔒
🔒score
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology,... more
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The compa... more
Description Shares
Market Cap$282.89BExchangeNYSE
SectorHealthcareIndustryDrug Manufacturers - General
CountryCHCEOVasant Narasimhan
IPO Date1996-11-07CAGR0.03%
Employees75,883Websitewww.novartis.com
Div. Yield3.2%Payout Ratio0.61%
Buy Back Yield2.96%Total Yield6.16%
NVS chart loading...
Fundamentals Technicals
Enterprise Value$331.72BP/E Ratio21.55
Forward P/E14.59PEG Ratio-2.24
P/S Ratio5.11P/B Ratio7.34
P/CF Ratio14.93P/FCF Ratio17.03
EPS$6.88EPS Growth 1Y9.23%
EPS Growth 3Y114.77%EPS Growth 5Y100.57%
Revenue Growth 1Y5.32%Gross Margin0.75%
Operating Margin0.3%Profit Margin0.24%
ROE0.32%ROA0.11%
ROCE0.19%Current Ratio0.85
Quick Ratio0.65Cash Ratio0.22
Debt/Equity1.22Interest Coverage13.57
Altman Z Score3.42Piotroski Score6

View Novartis financial charts →